Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

OBF1 and Oct factors control the germinal center transcriptional program

Shuang Song, Chun Cao, Mohamed-Amin Choukrallah, Fengyuan Tang, Gerhard Christofori, Hubertus Kohler, Fabian Wu, Barna D. Fodor, Mathias Frederiksen, Simon N. Willis, Jacob T. Jackson, Stephen L. Nutt, Stefan Dirnhofer, Michael B. Stadler, Patrick Matthias

Blood (2021) 137 (21): 2920–2934.

https://doi.org/10.1182/blood.2020010175

Published: 2021

Includes: Supplemental data

Journal Articles

An OCT2 / OCA-B / MEF2B Ternary Complex Controls the Activity and Architecture of an Essential Locus Control Region for Normal and Malignant Germinal Center B-Cells

Johannes C Hellmuth, MD, Chi-Shuen Chu, PhD, Rajat Singh, PhD, Lucy A Skrabanek, PhD, Ashley Doane, Olivier Elemento, PhD, Robert G. Roeder, PhD, Ari Melnick, MD

Blood (2019) 134 (Supplement_1): 24.

https://doi.org/10.1182/blood-2019-130692

Published: 2019

Journal Articles

Functional Characterization of Genes Driving Enhanced Biological Aggressiveness of Myeloma Cells: Identification of Novel and Understudied "Drivers" of Myeloma

Huihui Tang, PhD, Ryosuke Shirasaki, MD PhD, Ricardo De Matos Simoes, PhD, Sara Gandolfi, MD, Olga Dashevsky, PhD, Sondra L. Downey-Kopyscinski, PhD, Brian Glassner, PhD, Michal Sheffer, PhD, Megan Bariteau, BSc, John G Doench, PhD, Constantine S. Mitsiades, MD PhD

Blood (2019) 134 (Supplement_1): 313.

https://doi.org/10.1182/blood-2019-128919

Published: 2019

Journal Articles

CRISPR Activation Screen for Drivers of MM Cell Proliferation

Huihui Tang, PhD, Ricardo De Matos Simoes, PhD, Ryosuke Shirasaki, MD PhD, Olga Dashevsky, PhD, Brian Glassner, PhD, Sondra L. Downey-Kopyscinski, PhD, Sara Gandolfi, MD, Michal Sheffer, PhD, Megan Bariteau, BSc, John G Doench, PhD, Constantine S. Mitsiades, MD PhD

Blood (2018) 132 (Supplement 1): 3197.

https://doi.org/10.1182/blood-2018-99-118712

Published: 2018

Journal Articles

Identification of a Patients-Derived CD34+ Myeloma Cell Population with Tumor-Propagating Capacity and Resistance to Anticancer Drugs

Kentaro Serizawa, Hirokazu Tanaka, MD PhD, Ayano Fukui, MD, Ryosuke Fujiwara, MD, Keigo Sano, MD, Hiroaki Inoue, MD, Takahiro Kumode, MD, Yasuhiro Taniguchi, MD, Yasuyoshi Morita, MD, Luis Espinoza, MDPhD, Itaru Matsumura, MDPhD

Blood (2017) 130 (Supplement 1): 1774.

https://doi.org/10.1182/blood.V130.Suppl_1.1774.1774

Published: 2017

Journal Articles

Gray Zone Lymphoma (GZL) with Features Intermediate between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): A Pathologic Consensus Study with Patient Outcomes and Prognostication across 15 North American Centers

Blood (2017) 130 (Supplement 1): 375.

https://doi.org/10.1182/blood.V130.Suppl_1.375.375

Published: 2017

Journal Articles

Gray Zone Lymphoma (GZL) with Features Intermediate Between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): Pathologic Classification and Clinical Outcomes from a Multicenter Consensus Study

Blood (2016) 128 (22): 4145.

https://doi.org/10.1182/blood.V128.22.4145.4145

Published: 2016

Journal Articles

Progressive Epigenetic Programming during B Cell Maturation Is Reflected in a Continuum of Epigenetic Disease Phenotypes in Chronic Lymphocytic Leukemia

Blood (2015) 126 (23): 2436.

https://doi.org/10.1182/blood.V126.23.2436.2436

Published: 2015

Journal Articles

Detection of BCL2 Gene Rearrangements in the Reed-Sternberg Cells of Composite Lymphomas or Newly Diagnosed Hodgkin Lymphoma in Patients with a Previous Diagnosis of Follicular Lymphoma

Sheila J M O'Connor, PhD, Kathryn Turner, MSc, Catherine H Burton, MBBChir, MD MRCP, FRCPath, Andrew Jack, PhD

Blood (2014) 124 (21): 137.

https://doi.org/10.1182/blood.V124.21.137.137

Published: 2014

Journal Articles

Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma

Hongxiu Li, Mark S. Kaminski, Yifeng Li, Mehmet Yildiz, Peter Ouillette, Siân Jones, Heather Fox, Kathryn Jacobi, Kamlai Saiya-Cork, Dale Bixby, Daniel Lebovic, Diane Roulston, Kerby Shedden, Michael Sabel, Lawrence Marentette, Vincent Cimmino, Alfred E. Chang, Sami N. Malek

Blood (2014) 123 (10): 1487–1498.

https://doi.org/10.1182/blood-2013-05-500264

Published: 2014

Includes: Supplemental data

Journal Articles

Grey Zone Lymphoma, Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma: Better Results With CHOP-Like Regimens

Omar Nadeem, MD, Diana O Treaba, MD, Jorge J Castillo, MD, James N Butera, MD

Blood (2013) 122 (21): 5105.

https://doi.org/10.1182/blood.V122.21.5105.5105

Published: 2013

Journal Articles

MultiOmyx TM : A Novel Chemistry and Visualization Tools To Aid Resolution Of Discrepant Hodgkin Lymphoma Cases- A Single Slide Multiplex Assay For The Evaluation Of Classical Hodgkin Lymphoma

Alisha Adams, Alexander Bordwell, BS, Derek Bouman, Deanna Fisher, Denise Hollman, Michael Lazare, Emily Zebadua, Bobby Baravati, Pinky Tripathi, Michelle Li, Alexander S. Ross, PhD, Lawrence Weiss, M.D

Blood (2013) 122 (21): 2994.

https://doi.org/10.1182/blood.V122.21.2994.2994

Published: 2013

Journal Articles

Impact Of Epstein-Barr Viral Infection In The Regression Of Methotrexate-Induced Lymphoproliferative Diseases In Patients With Rheumatoid Arthritis

Tokuhira Michihide, Kimura Yuhta, Takahashi Yasuyuki, Tomikawa Tatsuki, Morihiko Sagawa, Tomoe Anan, Higashi Morihiro, Itoyama Shinji, Tamaru Jun-ichi, Okuyama Ayumi, Amano Koichi, Tabayashi Takayuki, Reiko Watanabe, M.D., Ph.D., Shigehisa Mori, MD, Masahiro Kizaki, MD

Blood (2013) 122 (21): 3006.

https://doi.org/10.1182/blood.V122.21.3006.3006

Published: 2013

Journal Articles

Recurrent STAT6 Mutations In Follicular Lymphoma

Sami Malek, MD, Mark S. Kaminski, MD, Hongxiu Li, PhD, Peter Ouillette, Sian Jones, PhD, Heather Fox, PA-C, Kathryn Jacobi, NP, Kamlai Saiya-Cork, Dale Bixby, MD, PhD, Daniel Lebovic, MD, Kerby Shedden, PhD, Michael Sabel, MD, Lawrence Marentette, MD, Vincent Cimmino, MD, Alfred Chang, MD, Mehmet Yildiz, MD

Blood (2013) 122 (21): 503.

https://doi.org/10.1182/blood.V122.21.503.503

Published: 2013

Journal Articles

Drug Transporters in Imatinib Resistance: A New Therapeutic Targeted Approach In CML

Raquel Alves, MSc student, Raquel Fonseca, MSc student, Ana Cristina Gonçalves, MSc, PhD student, Vera Alves, BSc, Ana Margarida Abrantes, MSc, PhD student, Filomena Botelho, MD, PhD, Ana Bela Sarmento-Ribeiro, MD, PhD

Blood (2011) 118 (21): 5010.

https://doi.org/10.1182/blood.V118.21.5010.5010

Published: 2011

Journal Articles

Prenyl Transferases Are Involved in the Regulation of CD20 Levels and Influence Anti-CD20 Monoclonal Antibody-Mediated Activation of Complement-Dependent Cytotoxicity,

Dominika Nowis, MD, PhD, Magdalena Winiarska, PhD, Jacek Bil, MD, PhD, Angelika Muchowicz, MSc, Malgorzata Wanczyk, MSc, Eliza Glodkowska-Mrowka, MD, Kamil Bojarczuk, BSc, Malgorzata Firczuk, PhD, Ewa Wilczek, PhD, Malgorzata Wachowska, MSc, Justyna Chlebowska, MSc, Michal Dwojak, Marta Miaczynska, PhD, Tomasz Stoklosa, MD, PhD, Jakub Golab, MD, PhD

Blood (2011) 118 (21): 3722.

https://doi.org/10.1182/blood.V118.21.3722.3722

Published: 2011

Journal Articles

OCT2 (Octamer Binding Protein 2): An Essential Role in Germinal Center B Cell Differentiation and the “Achilles Heel” of Derived Lymphomas.

Stella M Ranuncolo, MD., PhD, Vu Ngo, PhD, Georg Lenz, MD, Wenming Xiao, PhD, George Wright, Ph.D., Louis M. Staudt, MD, PhD

Blood (2009) 114 (22): 362.

https://doi.org/10.1182/blood.V114.22.362.362

Published: 2009

Journal Articles

The Emergence of Clonally Related Hodgkin Lymphoma Following B-Cell Malignancies Treated with Rituximab.

Catherine H Burton, MBBChir, MD, MRCP, FRCPath, Sheila J.M. zsnO'Connor, Roger G Owen, Andrew S Jack

Blood (2009) 114 (22): 3664.

https://doi.org/10.1182/blood.V114.22.3664.3664

Published: 2009

Journal Articles

Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma

Alexey Ushmorov, Frank Leithäuser, Olena Sakk, Andreas Weinhaüsel, Sergey W. Popov, Peter Möller, Thomas Wirth

Blood (2006) 107 (6): 2493–2500.

https://doi.org/10.1182/blood-2005-09-3765

Published: 2006

Journal Articles

Identification of Three Novel Chromosomal Translocation Partners Involving the Immunoglobulin Loci in Newly Diagnosed Myeloma and Human Myeloma Cell Lines.

Ichiro Hanamura, MD, Shinsuke Iida, MD, Ryuzo Ueda, MD, Michael Kuehl, MD, Contance Cullraro, Leif Bergsagel, MD, Jeffrey Sawyer, PhD, Bart Barlogie, MD, PhD, John Shaughnessy, Jr., PhD

Blood (2005) 106 (11): 1552.

https://doi.org/10.1182/blood.V106.11.1552.1552

Published: 2005

NARROW

OBF1 and Oct factors control the germinal center transcriptional program

An OCT2 / OCA-B / MEF2B Ternary Complex Controls the Activity and Architecture of an Essential Locus Control Region for Normal and Malignant Germinal Center B-Cells

Functional Characterization of Genes Driving Enhanced Biological Aggressiveness of Myeloma Cells: Identification of Novel and Understudied "Drivers" of Myeloma

CRISPR Activation Screen for Drivers of MM Cell Proliferation

Identification of a Patients-Derived CD34+ Myeloma Cell Population with Tumor-Propagating Capacity and Resistance to Anticancer Drugs

Gray Zone Lymphoma (GZL) with Features Intermediate between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): A Pathologic Consensus Study with Patient Outcomes and Prognostication across 15 North American Centers

Gray Zone Lymphoma (GZL) with Features Intermediate Between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): Pathologic Classification and Clinical Outcomes from a Multicenter Consensus Study

Progressive Epigenetic Programming during B Cell Maturation Is Reflected in a Continuum of Epigenetic Disease Phenotypes in Chronic Lymphocytic Leukemia

Detection of BCL2 Gene Rearrangements in the Reed-Sternberg Cells of Composite Lymphomas or Newly Diagnosed Hodgkin Lymphoma in Patients with a Previous Diagnosis of Follicular Lymphoma

Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma

Grey Zone Lymphoma, Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma: Better Results With CHOP-Like Regimens

MultiOmyx TM : A Novel Chemistry and Visualization Tools To Aid Resolution Of Discrepant Hodgkin Lymphoma Cases- A Single Slide Multiplex Assay For The Evaluation Of Classical Hodgkin Lymphoma

Impact Of Epstein-Barr Viral Infection In The Regression Of Methotrexate-Induced Lymphoproliferative Diseases In Patients With Rheumatoid Arthritis

Recurrent STAT6 Mutations In Follicular Lymphoma

Drug Transporters in Imatinib Resistance: A New Therapeutic Targeted Approach In CML

Prenyl Transferases Are Involved in the Regulation of CD20 Levels and Influence Anti-CD20 Monoclonal Antibody-Mediated Activation of Complement-Dependent Cytotoxicity,

OCT2 (Octamer Binding Protein 2): An Essential Role in Germinal Center B Cell Differentiation and the “Achilles Heel” of Derived Lymphomas.

The Emergence of Clonally Related Hodgkin Lymphoma Following B-Cell Malignancies Treated with Rituximab.

Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma

Identification of Three Novel Chromosomal Translocation Partners Involving the Immunoglobulin Loci in Newly Diagnosed Myeloma and Human Myeloma Cell Lines.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only